Skip to content

DExtrose as a MAiNtenance fluiD in Septic shock (DEMANDS) trial

DEXTROSE 5% VERSUS NORMAL SALINE AS MAINTENANCE FLUID THERAPY IN PATIENTS WITH SEPTIC SHOCK; A RANDOMIZED CONTROLLED TRIAL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
PACTR
Registry ID
PACTR202207871325490
Enrollment
100
Registered
2022-07-11
Start date
2022-07-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Circulatory System septic shock

Interventions

dextrose
normal saline

Sponsors

faculty of medicine Alexandria university
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: ? Septic shock defined as sepsis with persisting hypotension requiring vasopressors to maintain MAP = 65 mm Hg and having a serum lactate level >2 mmol/L (18 mg/dL) despite adequate volume resuscitation. ? Age = 18 years. ? Need for maintenance fluid as determined by the treating clinician ? Study intervention can be administered within 1 h of inclusion criteria being met.

Exclusion criteria

Exclusion criteria: ? Clinical situations that would render the primary endpoint difficult to interpret: • Chronic diuretic or decompression use. • Liver failure. • Treatment with parenteral feeding. • Confirmed or suspected pregnancy. • Patients in whom death is considered imminent (within 24 hours) ? Potential patient harm by the study fluids: • Severe heart failure. • Patients with intracranial pathology (eg; traumatic brain injury, Stroke). • Electrolyte disorders; ? A sodium level below 130 mmol/L or over 150 mmol/L or ? A potassium level below 3 mmol/L or over 5 mmol/L

Design outcomes

Primary

MeasureTime frame
•The net cumulative fluid balance after 72 hours in ICU.

Secondary

MeasureTime frame
• All-cause mortality at 28 days post randomization.; • The relative change in haemodynamic variables, blood gas results Lactate, and electrolytes over the 72 h post randomization. ;ICU length of stay;duration of vasopressor requirement ;vasopressor free days;dose of vasopressor used;requirement for ventilation;duratin of ventilator support;ventilator free days;requirement for renal replacement therapy;duration of renal replacement therapy;renal replacement therapy free days;AKIN score to day 7;serum sodium;delirium incidence;delirium and coma free days

Countries

Egypt

Contacts

Public ContactSamaa Abdelfatah

assisstant lecturer

Samaa.daoud@outlook.com00201062409640

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026